4//SEC Filing
TAYLOR GLEN A 4
Accession 0001062993-24-014054
CIK 0001840877other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:43 PM ET
Size
12.3 KB
Accession
0001062993-24-014054
Insider Transaction Report
Form 4
TAYLOR GLEN A
Director10% Owner
Transactions
- Award
Warrant (right to buy)
2024-07-22+250,000→ 250,000 total(indirect: By LLC)Exercise: $2.25From: 2024-07-22Exp: 2026-02-27→ Class A Common Stock (250,000 underlying)
Holdings
- 2,526,058(indirect: By Taylor Sports Group)
Class A Common Stock
- 4,810,384(indirect: By LLC)
Class A Common Stock
- 1,000,000(indirect: By LLC)
Series A Preferred Stock
Exercise: $11.50→ Class A Common Stock (869,565 underlying) - 2,953,607
Class A Common Stock
- 250,000(indirect: By LLC)
Warrant (right to buy)
Exercise: $3.04From: 2024-05-23Exp: 2026-02-27→ Class A Common Stock (250,000 underlying) - 500,000(indirect: By LLC)
Warrant (right to buy)
Exercise: $1.24From: 2024-02-27Exp: 2026-02-27→ Class A Common Stock (500,000 underlying)
Footnotes (4)
- [F1]The Reporting Person is the owner and chairman of Taylor Sports Group.
- [F2]GAT Funding, LLC is an entity controlled by the Reporting Person.
- [F3]Fully exercisable and there is no expiration date.
- [F4]In connection with the Issuer's draw under the promissory note issued in February 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Exhibit 10.1 of the Issuer's 10-Q as filed with the SEC on May 15, 2024.
Issuer
Envoy Medical, Inc.
CIK 0001840877
Entity typeother
Related Parties
1- filerCIK 0001213971
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 4:43 PM ET
- Size
- 12.3 KB